Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Stemtech (STEK) Research & Development (2023)

Stemtech (STEK) has disclosed Research & Development for 1 consecutive years, with $177.0 as the latest value for Q2 2023.

  • Quarterly Research & Development changed N/A to $177.0 in Q2 2023 from the year-ago period, while the trailing twelve-month figure was $177.0 through Mar 2024, down 98.72% year-over-year, with the annual reading at $13800.0 for FY2023, N/A changed from the prior year.
  • Research & Development hit $177.0 in Q2 2023 for Stemtech, down from $13800.0 in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $13800.0 in Q1 2023 to a low of $177.0 in Q2 2023.